ArticleRSC medicinal chemistry2020

Development of potent CPP6-gemcitabine conjugates against human prostate cancer cell line (PC-3).

Cristiana Correia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.